Companies in the genetics sector developing innovative solutions and technologies.
Explore 307 recently funded genetics companies with verified founder contact information and fundraising data.
Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.
Ohmic Biosciences uses protein engineering technology in providing solutions to any disease in any crop.
EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
Full Genomes uses sequencing technology to provide services such as reports on a customer's ancestry, genealogy, and family history.
Nionyx Bio builds AAV-based gene therapies to address some of the most potent kidney genetic diseases.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Regel Therapeutics provides gene therapy that significantly improve the lives of people with life-threatening genetic illnesses.
Lifebit CloudOS is the intelligent genomics platform that is the industry standard for unified, secure research over distributed big data.
Arcturus Therapeutics is a clinical-stage company specializing in mRNA medicines and vaccines.
Redefining Sample Preparation, Revolutionizing Genomics
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system.
Nvelop Therapeutics is a biotechnology company that developes genetic medicines for patients with severe genetic diseases.
Preclinical biotech with deep expertise in functional genomics to map genetic variants and advance a rare disease pipeline led by CB-001.
Ubiquitome offers genomic information solutions with portable cloud-connected genetic analysis devices.
HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.
Tailwind Biotech offers AI-powered synthetic DNA design services for biomanufacturing companies.
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits.
Algen Biotechnologies is a therapeutic discovery company that builds a platform to decode functional gene networks.
Fermelanta is a biotech firm that produces rare plant-based ingredients through microbial fermentation.
Nygen Analytics offers cloud-based solutions for sustainable and cost-effective analysis of single-cell genomic data.
Molecular Assemblies is developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products.
The genetics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Genetics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The genetics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 307 genetics companies tracked in the VCBacked database.
Companies in the genetics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting genetics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked